Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ProMIS Neurosciences Inc
PMN
Healthcare
Biotechnology
ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine...
applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PMN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(92)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on May 05, 2024 12:20am
RE:It's Time!
Looks like a stop-loss on Wednesday morning momentarily took the price down to 1.40, so where was the market? And you think it takes a rumour to hold the price down?
(10)
•••
Lynx9
X
View Profile
View Bullboard History
Post by
Lynx9
on May 04, 2024 2:33pm
It's Time!
Isn't it time for another juicy rumour to start circulating amongst the faithful to hold the price at $2us.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 03, 2024 4:47pm
@ the Bell: TSX powers through to close week higher
Canada’s main stock index inched up on Friday. The only drag on the TSX was a drop in the energy sector while mining led gains.
read article.
(92)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on May 03, 2024 10:50am
RE:Toxic oligomer hypothesis
Probably not fair to blame the "scientific community" for being slow to get off the plaque train, the science hopped off 1-3 decades ago so the "forward" motion we see now is just
...more
(81)
•••
Gbathat
X
View Profile
View Bullboard History
Comment by
Gbathat
on May 02, 2024 7:53pm
RE:Toxic oligomer hypothesis
Timing is everything. Experienced investors are looking at the same milestones as us and saying, why get in now when my money could be growing elsewhere? But we are getting close to
...more
(38)
•••
BottomBroker
X
View Profile
View Bullboard History
Comment by
BottomBroker
on May 02, 2024 1:46pm
RE:Toxic oligomer hypothesis
You're unusually optimistic....
(88)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on May 02, 2024 1:17pm
Toxic oligomer hypothesis
Why is it we don't get any credit for PMN310? Simple, it has been decades saying that plaque causes Alzheimer's. Now the scientific community is just starting to recognize that toxic oligomers
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 02, 2024 8:22am
Buzz on the Bullboards: The top stocks in energy, mining and EVs
While energy gains propel the TSX, industrials get attention from the EV market and investors navigate another week of mining sector activity.
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 30, 2024 7:00am
New Press Release - ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
Study results support differentiation of PMN310 from other amyloid-beta-directed antibodies CAMBRIDGE, Massachusetts and TORONTO, Ontario, April 30, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody...
read article.
(88)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Apr 29, 2024 3:40pm
TOXIC OLIGOMERS / JUNE DATA
The incidence of Alzheimer's disease (AD) is growing every day and finding an effective treatment is becoming more vital. Amyloid-β (Aβ) has been the focus of research for several decades. The
...more
(88)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Apr 29, 2024 4:25am
Prothena
Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease. I don't know how you can
...more
(1)
•••
farmerlucy
X
View Profile
View Bullboard History
Comment by
farmerlucy
on Apr 28, 2024 5:39pm
RE:RE:1A Results/Market Awareness
A deal with a Pharma company that could leverage Promis's platform, Alzhemers might not work out, perhaps ALS , PD, vaccines have a better shot. Diagnostics clearly heading into alzheimers
...more
(92)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Apr 28, 2024 5:17pm
RE:RE:1A Results/Market Awareness
Yup, 1A unlikely to be a market mover. I cannot imagine the investor out there sitting on 1a results. Granted Pfizer made a killing (literal and figurative) with a "vaccine"
...more
(1)
•••
farmerlucy
X
View Profile
View Bullboard History
Comment by
farmerlucy
on Apr 28, 2024 5:01pm
RE:1A Results/Market Awareness
I wish you were right but the fact is Promis over the last couple of years has just been testing animals and humans not alzheimers patients. Numerous companies have passed phase 1 safety results
...more
(88)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Apr 28, 2024 11:25am
1A Results/Market Awareness
When the 1A results are released in June the market will begin to put us on their radar screen and news letter writers will comment to their clients. Our ridiculous market cap will be gone and
...more
(92)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Apr 26, 2024 11:42pm
RE:RE:RE:The only scenario
I wasn't aware I had a conspiracy theory, how does it go?
(88)
•••
goldtech
X
View Profile
View Bullboard History
Comment by
goldtech
on Apr 26, 2024 7:39pm
RE:RE:The only scenario
Partnership, joint venture, collaboration, call it what you want but if we succeed then credits will be afforded to the entire platform. This all stems on the two scenarios and if successful, big
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon